MedTrace Logo

Uppsala Psychosis Cohort

NCT05763966 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-02-20

No results posted yet for this study

Summary

A multimodal longitudinal study in early stage psychosis patients and individuals at high risk for psychosis. Healthy controls are included for baseline comparisons. The aim is to investigate disease mechanisms of psychotic disorders, specifically focusing on the synaptic pruning hypothesis.

Conditions

  • Schizophrenia; Psychosis

Interventions

OTHER

No intervention

Observational study where participants are followed over time

Sponsors & Collaborators

  • Uppsala University Hospital

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Simon Cervenka, MD, PhD · Uppsala University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-12-31
Completion
2031-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05763966 on ClinicalTrials.gov